14. March 2023 | Corporate News

Marinomed Biotech AG reports positive clinical data for the Carragelose decongestant nasal spray

  • Clinical data shows a significant decongestant effect of the Sorbitol-containing Carragelose nasal spray in allergic rhinitis patients
  • The product utilizes the effect of Sorbitol as treatment of a blocked nose without the side effect of habituation
  • The results of the study are important for the switch to the Medical Device Regulation (MDR) and will support the marketing of the product

 

The full press release is available as download here: 

Marinomed Biotech AG reports positive clinical data for the Carragelose decongestant nasal spray
(60 KB)